MyAverix Finance
US · Healthcare
Citius Oncology, Inc. (CTOR)
Drug Manufacturers - Specialty & Generic
Citius Oncology, Inc. (CTOR) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CTOR
Citius Oncology, Inc. (CTOR) — FAQ
What is CTOR's P/E ratio?
The price-to-earnings (P/E) ratio for Citius Oncology, Inc. (CTOR) is 18.00 (data as of 2026-03-24).
Does Citius Oncology, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Citius Oncology, Inc. (CTOR). Check the MyAverix Finance app for the latest dividend data.
What sector is Citius Oncology, Inc. in?
Citius Oncology, Inc. (CTOR) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CTOR listed on?
CTOR is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.